The novel drug reconstitution systems market is anticipated to grow a sustained rate, claims Roots A

Roots Analysis has announced the addition of “Novel Drug Reconstitution Systems Market, 2021-2030” report to its list of offerings.

Given the large number of steps involved, multiple containers, and risk of medication errors associated with the use of traditional reconstitution methods, the pharmaceutical industry has progressed towards developing novel drug reconstitution systems. These advanced systems contain premeasured dose of drug and diluent, which essentially reduces the chances of dosing errors, enhance the portability, efficiency and optimum delivery of lyophilized drugs, thereby improving the provision of healthcare.

To order this 320+ page report, which features 230 figures and 248 tables, please visit